The headline-grabbing weight-loss drugs of the last few years were just the beginning. In 2026, we are entering the second generation of metabolic pharmaceuticals. These new medications are designed to do more than just suppress appetite; they are targeting the cellular mitochondria to improve how the body burns energy. This "mitochondrial repair" approach could potentially treat metabolic...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek